tiprankstipranks
Vaxil Bio Ltd (TSE:VXL)
TSXV:VXL
Canadian Market

Vaxil Bio (VXL) Financial Statements

18 Followers

Vaxil Bio Financial Overview

Vaxil Bio's market cap is currently ―. The company's EPS TTM is C$-0.001; its P/E ratio is -7.14; Vaxil Bio is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -58.00KC$ 26.00KC$ -28.00KC$ -127.00KC$ -125.00K
EBITDAC$ -58.00KC$ 26.00KC$ -28.00KC$ -127.00KC$ -125.00K
Net Income Common StockholdersC$ -58.00KC$ 26.00KC$ -28.00KC$ -127.00KC$ -125.00K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 920.00KC$ 938.00KC$ 1.01MC$ 1.06MC$ 1.34M
Total AssetsC$ 933.00KC$ 976.00KC$ 1.05MC$ 1.12MC$ 1.36M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -920.00KC$ -938.00KC$ -1.01MC$ -1.06MC$ -1.34M
Total LiabilitiesC$ 98.00KC$ 85.00KC$ 190.00KC$ 234.00KC$ 353.00K
Stockholders EquityC$ 835.00KC$ 891.00KC$ 860.00KC$ 887.00KC$ 1.01M
Cash Flow-
Free Cash FlowC$ -20.00KC$ -69.00KC$ -49.00KC$ -279.00KC$ -164.00K
Operating Cash FlowC$ -20.00KC$ -69.00KC$ -49.00KC$ -279.00KC$ -164.00K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CAD

Vaxil Bio Earnings and Revenue History

Vaxil Bio Debt to Assets

Vaxil Bio Cash Flow

Vaxil Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis